Last $6.43 HKD
Change Today -0.02 / -0.31%
Volume 22.0M
1093 On Other Exchanges
Hong Kong
As of 4:01 AM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

cspc pharmaceutical group lt (1093) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/12/14 - $8.49
52 Week Low
10/3/13 - $4.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CSPC PHARMACEUTICAL GROUP LT (1093)

Related News

No related news articles were found.

cspc pharmaceutical group lt (1093) Related Businessweek News

No Related Businessweek News Found

cspc pharmaceutical group lt (1093) Details

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs. In addition, it researches and develops approximately 170 products for therapeutic areas of anti-infective, cardio-cerebrovascular, diabetes, neurology, and oncology. Further, the company offers pharmaceutical research and development services; and sewage treatment services. It has operations primarily in the People’s Republic of China, other Asian regions, the Americas, and Europe. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. The company is based in Wan Chai, Hong Kong and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange.

10,391 Employees
Last Reported Date: 09/11/14

cspc pharmaceutical group lt (1093) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: $10.8M
Executive Director
Total Annual Compensation: $3.9M
Executive Director
Total Annual Compensation: $760.0K
Executive Director
Total Annual Compensation: $760.0K
Executive Director
Total Annual Compensation: $760.0K
Compensation as of Fiscal Year 2013.

cspc pharmaceutical group lt (1093) Key Developments

CSPC Pharmaceutical Group Limited(SEHK:1093) added to Hang Seng China Affiliated Corporations Index

CSPC Pharmaceutical Group Limited will be added to the Hang Seng China Affiliated Corporations Index.

CSPC Pharmaceutical Group Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014

CSPC Pharmaceutical Group Limited announced unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, revenue was HKD 5,342,470,000, operating profit was HKD 801,446,000 and profit before taxation was HKD 771,689,000 and profit for the period was HKD 609,426,000 against revenue of HKD 5,075,665,000, operating profit of HKD 582,370,000 and profit before taxation of HKD 651,644,000 and profit for the period of HKD 527,830,000 for the same period a year ago. Profit for the period attributable to owners of the company was HKD 600,665,000 against HKD 515,201,000 a year ago. Earnings per diluted share was 10.07 cents against 8.81 cents a year ago. For the first half of 2014, the Group's operating activities generated a net cash inflow of HKD 1,010 million. Capital expenditure in relation to the additions of production facilities amounted to HKD 397 million for the current period.

CSPC Pharmaceutical Group Limited to Report First Half, 2014 Results on Aug 26, 2014

CSPC Pharmaceutical Group Limited announced that they will report first half, 2014 results on Aug 26, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1093:HK $6.43 HKD -0.02

1093 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1093.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1093 Industry Range
Price/Earnings 36.0x
Price/Sales 3.7x
Price/Book 5.1x
Price/Cash Flow 35.8x
TEV/Sales 3.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSPC PHARMACEUTICAL GROUP LT, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at